Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Human traumatic brain injury induces autoantibody response against glial fibrillary acidic protein and its breakdown products.

Zhang Z, Zoltewicz JS, Mondello S, Newsom KJ, Yang Z, Yang B, Kobeissy F, Guingab J, Glushakova O, Robicsek S, Heaton S, Buki A, Hannay J, Gold MS, Rubenstein R, Lu XC, Dave JR, Schmid K, Tortella F, Robertson CS, Wang KK.

PLoS One. 2014 Mar 25;9(3):e92698. doi: 10.1371/journal.pone.0092698. eCollection 2014. Erratum in: PLoS One. 2014;9(6):e101712.

2.

Plasma Anti-Glial Fibrillary Acidic Protein Autoantibody Levels during the Acute and Chronic Phases of Traumatic Brain Injury: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot Study.

Wang KK, Yang Z, Yue JK, Zhang Z, Winkler EA, Puccio AM, Diaz-Arrastia R, Lingsma HF, Yuh EL, Mukherjee P, Valadka AB, Gordon WA, Okonkwo DO, Manley GT, Cooper SR, Dams-O'Connor K, Hricik AJ, Inoue T, Maas AI, Menon DK, Schnyer DM, Sinha TK, Vassar MJ.

J Neurotrauma. 2016 Jul 1;33(13):1270-7. doi: 10.1089/neu.2015.3881. Epub 2016 Feb 1.

3.

Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats.

Huang XJ, Glushakova O, Mondello S, Van K, Hayes RL, Lyeth BG.

J Neurotrauma. 2015 Aug 15;32(16):1179-89. doi: 10.1089/neu.2015.3873. Epub 2015 May 14.

PMID:
25763798
4.

GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome.

Pelinka LE, Kroepfl A, Leixnering M, Buchinger W, Raabe A, Redl H.

J Neurotrauma. 2004 Nov;21(11):1553-61.

PMID:
15684648
5.

Glial fibrillary acidic protein is highly correlated with brain injury.

Lumpkins KM, Bochicchio GV, Keledjian K, Simard JM, McCunn M, Scalea T.

J Trauma. 2008 Oct;65(4):778-82; discussion 782-4. doi: 10.1097/TA.0b013e318185db2d.

PMID:
18849790
6.

Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Novel Meningoencephalomyelitis.

Fang B, McKeon A, Hinson SR, Kryzer TJ, Pittock SJ, Aksamit AJ, Lennon VA.

JAMA Neurol. 2016 Nov 1;73(11):1297-1307. doi: 10.1001/jamaneurol.2016.2549.

PMID:
27618707
7.

Vimentin and GFAP responses in astrocytes after contusion trauma to the murine brain.

Ekmark-Lewén S, Lewén A, Israelsson C, Li GL, Farooque M, Olsson Y, Ebendal T, Hillered L.

Restor Neurol Neurosci. 2010;28(3):311-21. doi: 10.3233/RNN-2010-0529.

PMID:
20479526
8.

Measurement of the glial fibrillary acidic protein and its breakdown products GFAP-BDP biomarker for the detection of traumatic brain injury compared to computed tomography and magnetic resonance imaging.

McMahon PJ, Panczykowski DM, Yue JK, Puccio AM, Inoue T, Sorani MD, Lingsma HF, Maas AI, Valadka AB, Yuh EL, Mukherjee P, Manley GT, Okonkwo DO; TRACK-TBI Investigators.

J Neurotrauma. 2015 Apr 15;32(8):527-33. doi: 10.1089/neu.2014.3635. Epub 2015 Jan 26.

9.

Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma.

Pelinka LE, Kroepfl A, Schmidhammer R, Krenn M, Buchinger W, Redl H, Raabe A.

J Trauma. 2004 Nov;57(5):1006-12.

PMID:
15580024
10.

Longitudinal changes in the DTI measures, anti-GFAP expression and levels of serum inflammatory cytokines following mild traumatic brain injury.

Singh K, Trivedi R, Devi MM, Tripathi RP, Khushu S.

Exp Neurol. 2016 Jan;275 Pt 3:427-435. doi: 10.1016/j.expneurol.2015.07.016. Epub 2015 Jul 26.

PMID:
26216663
11.

Serum Glial Fibrillary Acidic Protein Predicts Tissue Glial Fibrillary Acidic Protein Break-Down Products and Therapeutic Efficacy after Penetrating Ballistic-Like Brain Injury.

Boutté AM, Deng-Bryant Y, Johnson D, Tortella FC, Dave JR, Shear DA, Schmid KE.

J Neurotrauma. 2016 Jan 1;33(1):147-56. doi: 10.1089/neu.2014.3672. Epub 2015 Jun 8.

PMID:
25789543
12.

GFAP-BDP as an acute diagnostic marker in traumatic brain injury: results from the prospective transforming research and clinical knowledge in traumatic brain injury study.

Okonkwo DO, Yue JK, Puccio AM, Panczykowski DM, Inoue T, McMahon PJ, Sorani MD, Yuh EL, Lingsma HF, Maas AI, Valadka AB, Manley GT; Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Investigators.

J Neurotrauma. 2013 Sep 1;30(17):1490-7. doi: 10.1089/neu.2013.2883. Epub 2013 Aug 1.

13.

Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein.

Diaz-Arrastia R, Wang KK, Papa L, Sorani MD, Yue JK, Puccio AM, McMahon PJ, Inoue T, Yuh EL, Lingsma HF, Maas AI, Valadka AB, Okonkwo DO, Manley GT; TRACK-TBI Investigators.

J Neurotrauma. 2014 Jan 1;31(1):19-25. doi: 10.1089/neu.2013.3040. Epub 2013 Oct 9.

14.

Characterization of Antibodies that Detect Human GFAP after Traumatic Brain Injury.

Zoltewicz JS, Scharf D, Yang B, Chawla A, Newsom KJ, Fang L.

Biomark Insights. 2012;7:71-9. doi: 10.4137/BMI.S9873. Epub 2012 Jun 25.

15.

Glial fibrillary acidic protein as a biomarker in severe traumatic brain injury patients: a prospective cohort study.

Lei J, Gao G, Feng J, Jin Y, Wang C, Mao Q, Jiang J.

Crit Care. 2015 Oct 12;19:362. doi: 10.1186/s13054-015-1081-8.

16.

Sequential changes in glial fibrillary acidic protein and gene expression following parasagittal fluid-percussion brain injury in rats.

Dietrich WD, Truettner J, Zhao W, Alonso OF, Busto R, Ginsberg MD.

J Neurotrauma. 1999 Jul;16(7):567-81.

PMID:
10447069
17.
18.

Dynamics of PDGFRβ expression in different cell types after brain injury.

Kyyriäinen J, Ekolle Ndode-Ekane X, Pitkänen A.

Glia. 2017 Feb;65(2):322-341. doi: 10.1002/glia.23094. Epub 2016 Oct 25.

PMID:
27778377
19.

Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome.

Nylén K, Ost M, Csajbok LZ, Nilsson I, Blennow K, Nellgård B, Rosengren L.

J Neurol Sci. 2006 Jan 15;240(1-2):85-91. Epub 2005 Nov 2.

PMID:
16266720
20.

Protective effects of glial cell line-derived neurotrophic factor on hippocampal neurons after traumatic brain injury in rats.

Kim BT, Rao VL, Sailor KA, Bowen KK, Dempsey RJ.

J Neurosurg. 2001 Oct;95(4):674-9.

PMID:
11596962

Supplemental Content

Support Center